Sunshine Biopharma (SBFM) EBT Margin (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly EBT Margin came in at 15.38% in Q1 2026, down 167.0% YoY from 22.95% in Q1 2025, and up 23.87% on a QoQ basis from 20.2% in Q4 2025.
Sunshine Biopharma (SBFM) EBT Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 10 years of EBT Margin data on file, last reported at 15.38% in Q1 2026.
- Quarterly EBT Margin fell 167.0% year-over-year to 15.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.84% (down 214.0% YoY) and the FY2025 annual result came in at 16.4%, down 100.0% from the prior year.
- EBT Margin climbed to 15.38% in Q1 2026, from 20.2% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 9.01% in Q2 2024 to a low of 1097.09% in Q3 2022.
- A 5-year average of 192.29% and a median of 16.73% in 2024 frame the typical range for EBT Margin.
- The widest YoY moves for EBT Margin: up 1443245 bps in 2022, down 137462 bps in 2022.
- Tracing SBFM's EBT Margin over 5 years: stood at 590.86% in 2022, then surged by 98 bps to 13.41% in 2023, then tumbled by 78 bps to 23.83% in 2024, then grew by 15 bps to 20.2% in 2025, then climbed by 24 bps to 15.38% in 2026.
- The last three EBT Margin figures came in at 15.38% (Q1 2026), 20.2% (Q4 2025), and 10.84% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | -16.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.88% |
| Mar 31, 2026 | -15.38% |
| Dec 31, 2025 | -20.20% |
| Sep 30, 2025 | -10.84% |
| Jun 30, 2025 | -21.04% |
| Mar 31, 2025 | -13.71% |
| Dec 31, 2024 | -23.83% |
| Sep 30, 2024 | -11.65% |
| Jun 30, 2024 | -9.01% |
| Mar 31, 2024 | -16.73% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | -10.25% |
| Jun 30, 2023 | -14.65% |
| Mar 31, 2023 | -33.84% |
| Dec 31, 2022 | -590.86% |
| Sep 30, 2022 | -1,097.09% |
| Jun 30, 2022 | -358.51% |
| Mar 31, 2022 | -1,007.98% |
| Dec 31, 2021 | 783.75% |
| Sep 30, 2021 | -8,018.47% |